List of Portola Pharmaceuticals patents

Patents where

Current Assignee

Name

Portola Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7358257 Platelet ADP receptor inhibitors	Patent 7358257 was granted and assigned to Portola Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	7358257	April 15, 2008
‌ US Patent 8367689 Inhibitors of JAK	Patent 8367689 was granted and assigned to Portola Pharmaceuticals on February, 2013 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	8367689	February 5, 2013
‌ US Patent 9587233 Antidotes for factor XA inhibitors and methods of using the same	Patent 9587233 was granted and assigned to Portola Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	9587233	March 7, 2017
‌ US Patent 8455441 Antidotes for factor Xa inhibitors and methods of using the same	Patent 8455441 was granted and assigned to Portola Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	8455441	June 4, 2013
‌ US Patent 9109046 Antidotes for factor Xa inhibitors and methods of using the same	Patent 9109046 was granted and assigned to Portola Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	9109046	August 18, 2015
‌ US Patent 9388401 Antidotes for factor Xa inhibitors and methods of using the same	Patent 9388401 was granted and assigned to Portola Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	9388401	July 12, 2016
‌ US Patent 9062298 Antidotes for factor XA inhibitors and methods of using the same	Patent 9062298 was granted and assigned to Portola Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	9062298	June 23, 2015
‌ US Patent 8455439 Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents	Patent 8455439 was granted and assigned to Portola Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	8455439	June 4, 2013
‌ US Patent 8153590 Antidotes for factor Xa inhibitors and methods of using the same	Patent 8153590 was granted and assigned to Portola Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	8153590	April 10, 2012
‌ US Patent 9056106 Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same	Patent 9056106 was granted and assigned to Portola Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	9056106	June 16, 2015
‌ US Patent 9579320 Inhibitors of syk and JAK protein kinases	Patent 9579320 was granted and assigned to Portola Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	9579320	February 28, 2017
‌ US Patent 8952027 Inhibitors of syk and JAK protein kinases	Patent 8952027 was granted and assigned to Portola Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	8952027	February 10, 2015
‌ US Patent 7358091 Device and methods for identifying and treating aspirin non-responsive patients	Patent 7358091 was granted and assigned to Portola Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	7358091	April 15, 2008
‌ US Patent 8349860 Inhibitors of syk and JAK protein kinases	Patent 8349860 was granted and assigned to Portola Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	8349860	January 8, 2013
‌ US Patent 8138339 Inhibitors of protein kinases	Patent 8138339 was granted and assigned to Portola Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	8138339	March 20, 2012
‌ US Patent 8889129 Antidotes for factor Xa inhibitors and methods of using the same	Patent 8889129 was granted and assigned to Portola Pharmaceuticals on November, 2014 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	8889129	November 18, 2014
‌ US Patent 9040530 1,2,4-triazine-6-carboxamide kinase inhibitors	Patent 9040530 was granted and assigned to Portola Pharmaceuticals on May, 2015 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	9040530	May 26, 2015
‌ US Patent 8853230 Inhibitors of JAK	Patent 8853230 was granted and assigned to Portola Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	8853230	October 7, 2014
‌ US Patent 9359308 Pyrazine kinase inhibitors	Patent 9359308 was granted and assigned to Portola Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	9359308	June 7, 2016
‌ US Patent 8258144 Inhibitors of protein kinases	Patent 8258144 was granted and assigned to Portola Pharmaceuticals on September, 2012 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	8258144	September 4, 2012
‌ US Patent 9902688 Benzamides and nicotinamides as Syk modulators	Patent 9902688 was granted and assigned to Portola Pharmaceuticals on February, 2018 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	9902688	February 27, 2018
‌ US Patent 7678913 Ureas as factor Xa inhibitors	Patent 7678913 was granted and assigned to Portola Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	7678913	March 16, 2010
‌ US Patent 7678790 Platelet ADP receptor inhibitors	Patent 7678790 was granted and assigned to Portola Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	7678790	March 16, 2010
‌ US Patent 8067428 Platelet ADP receptor inhibitors	Patent 8067428 was granted and assigned to Portola Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.		Portola Pharmaceuticals	United States Patent and Trademark Office	8067428	November 29, 2011
‌ US Patent 9023796 Antidotes for factor XA inhibitors and methods of using the same	Patent 9023796 was granted and assigned to Portola Pharmaceuticals on May, 2015 by the United States Patent and Trademark Office.	Portola Pharmaceuticals	Portola Pharmaceuticals	United States Patent and Trademark Office	9023796	May 5, 2015

Results per page:

62 results

0 selected

62 results

0 selected